agenc rate corpor level
initi credit coverag underweight
initi coverag credit underweight
recommend base expect deterior
credit profil driven aggress financi polici
recent debt fund acquisit acel result higher leverag
softer underli ebitda outlook driven weaker trend china
automot electron end market neg rate trend
histor manufactur
pfas/pfoa believ rel valu fulli reflect
neg headwind face credit bond spread modestli
lag singl peer year date current trade
trade given outlook rise leverag
estim issuanc acel acquisit neg headlin relat
pfas/pfoa litig potenti downsid rate action expect
spread under-perform
aggress financi policy/debt fund acquisit
acel began adopt aggress financi polici
initi multi-year increas cash return
sharehold commit partial debt fund
updat commit share
buyback time frame acquir scott safeti
busi result action leverag
increas end may
announc cash acquisit advanc wound
medic care compani acel ev expect
close see pro forma leverag rise
softer underli ebitda driven weaker result china
automot electron end market report weaker
expect result lower guidanc full year
organ currency-neutr revenu declin volum
price segment industri
consum oper margin decreas
driven lower volum product partial off-set
net price benefit compani implement cost reduct
program includ elimin posit expect
save remaind year save
annual afterward fiscal lower outlook
follow organ revenu prior
ep prior continu see free
cash flow convers equiti research steve tusa
forecast ebitda vs
compani report earn thursday juli
neg rate trend rate migrat lower
last ten year mid aa aa-/neg given
page analyst certif import disclosur
 morgan seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report singl
factor make invest decis
compani aggress financi polici softer financi
outlook rise litig concern see downsid
rate time
litig risk relat environment matter includ
histor manufactur pfa rise though still earli
stage face numer lawsuit across
manufactur pfa chemic link cancer
health problem use make non-stick films/coat
includ teflon fire-fight foam note name
defend lawsuit file new hampshir new jersey
new york pennsylvania attorney gener seek remedi
multipl larg pfa contamin site among thing
addit michigan attorney gener evalu legal
strategi potenti lawsuit compani lastli
multi-district litig assembl south carolina
alleg person injuri need medic monitor properti
damag econom loss took charg
relat environment liabil includ pfa
ultim financi liabil difficult estim could
take year resolv believ overhang
credit weigh sentiment
dont believ bond spread fulli reflect neg
trend face credit though bond modestli lag
high qualiti singl peer year date see
downsid underli busi trend weaker leverag
rise rel high qualiti manufactur name like
siegr utx
risk underweight recommend includ better
expect ebitda trend next year could
result leverag rise much expect come
faster chang conserv financi polici quick
financi benign resolut environmental/leg matter
headquart minnesota diversifi global manufactur compani
oper footprint countri revenu approxim
revenu outsid us wide rang product
servic span consum healthcar industri end market compani invest
heavili busi capital-expenditure approxim sale strong
track record technolog led innov follow busi segment realign
earlier year oper four busi segment safeti industri
transport electron health consum
figur revenu segment
figur revenu geographi
million
compani report note result ltm latest quarter figur reflect manufactur busi
summari financi
cash equival
flow oper activ
o/w chang work capit
flow invest activ
sale
flow financ activ
net chang cash
adj free cash flow firm
compani report morgan equiti estim publish may
note million except per-shar data fiscal year end dec o/w
analyst certif author name within report research analyst unless otherwis specifi research analyst
denot ac cover report certifi multipl research analyst primarili respons report
research analyst denot ac cover within document individu certifi respect secur issuer
research analyst cover research view express report accur reflect person view
subject secur issuer part research analyst compens
directli indirectli relat specif recommend view express research analyst report korea-
base research analyst list front cover applic also certifi per kofia requir analysi made
good faith view reflect opinion without undu influenc intervent
